Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Elizabeth Doyle DNP, APRN, BC-ADM, CDCES

Elizabeth A. Doyle DNP, APRN, BC-ADM, CDCES

Associate Professor, Yale School of Nursing, Orange Connecticut; Pediatric Nurse Practitioner, Yale Children’s Diabetes Program, Yale New Haven Hospital, New Haven, Connecticut

Dr. Doyle is an associate professor at the Yale School of Nursing, and a pediatric nurse practitioner who has cared for children and young adults with type 1 and type 2 diabetes for almost 30 years. After completing her bachelor’s degree at Villanova University in 1989, she went on to obtain her Master’s Degree in Nursing from Yale School of Nursing in 1995, and her Doctor of Nursing Practice degree from Fairfield University in 2016.  She has had a special interest specifically in diabetes technology that can improve metabolic control and make diabetes management less burdensome for families. In fact, she was one of the initial investigators and clinicians who demonstrated that insulin pump therapy is indeed safe and effective in caring for adolescents with diabetes. Her current clinical practice is with the Yale Pediatric Diabetes Program at the YNHH Children’s Satellite office in Norwalk, CT. Additionally, as an associate professor at the Yale School of Nursing, she leads their diabetes concentration, helping to prepare future clinicians caring for patients with diabetes across the lifespan.


Dr. Doyle has no relevant disclosures.